Cargando…
Recent Advances for Dynamic-Based Therapy of Atherosclerosis
Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy for AS is administering drugs and performing surgery. However, advanced therapy strategies are urgently required because of the deficient therapeutic eff...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352141/ https://www.ncbi.nlm.nih.gov/pubmed/37469455 http://dx.doi.org/10.2147/IJN.S402678 |
_version_ | 1785074454942973952 |
---|---|
author | Wu, Guanghao Yu, Guanye Zheng, Meiling Peng, Wenhui Li, Lei |
author_facet | Wu, Guanghao Yu, Guanye Zheng, Meiling Peng, Wenhui Li, Lei |
author_sort | Wu, Guanghao |
collection | PubMed |
description | Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy for AS is administering drugs and performing surgery. However, advanced therapy strategies are urgently required because of the deficient therapeutic effects of current managements. Increased number of energy conversion-based organic or inorganic materials has been used in cancer and other major disease treatments, bringing hope to patients with the development of nanomedicine and materials. These treatment strategies employ specific nanomaterials with specific own physiochemical properties (external stimuli: light or ultrasound) to promote foam cell apoptosis and cholesterol efflux. Based on the pathological characteristics of vulnerable plaques, energy conversion-based nano-therapy has attracted increasing attention in the field of anti-atherosclerosis. Therefore, this review focuses on recent advances in energy conversion-based treatments. In addition to summarizing the therapeutic effects of various techniques, the regulated pathological processes are highlighted. Finally, the challenges and prospects for further development of dynamic treatment for AS are discussed. |
format | Online Article Text |
id | pubmed-10352141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103521412023-07-19 Recent Advances for Dynamic-Based Therapy of Atherosclerosis Wu, Guanghao Yu, Guanye Zheng, Meiling Peng, Wenhui Li, Lei Int J Nanomedicine Review Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy for AS is administering drugs and performing surgery. However, advanced therapy strategies are urgently required because of the deficient therapeutic effects of current managements. Increased number of energy conversion-based organic or inorganic materials has been used in cancer and other major disease treatments, bringing hope to patients with the development of nanomedicine and materials. These treatment strategies employ specific nanomaterials with specific own physiochemical properties (external stimuli: light or ultrasound) to promote foam cell apoptosis and cholesterol efflux. Based on the pathological characteristics of vulnerable plaques, energy conversion-based nano-therapy has attracted increasing attention in the field of anti-atherosclerosis. Therefore, this review focuses on recent advances in energy conversion-based treatments. In addition to summarizing the therapeutic effects of various techniques, the regulated pathological processes are highlighted. Finally, the challenges and prospects for further development of dynamic treatment for AS are discussed. Dove 2023-07-13 /pmc/articles/PMC10352141/ /pubmed/37469455 http://dx.doi.org/10.2147/IJN.S402678 Text en © 2023 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Wu, Guanghao Yu, Guanye Zheng, Meiling Peng, Wenhui Li, Lei Recent Advances for Dynamic-Based Therapy of Atherosclerosis |
title | Recent Advances for Dynamic-Based Therapy of Atherosclerosis |
title_full | Recent Advances for Dynamic-Based Therapy of Atherosclerosis |
title_fullStr | Recent Advances for Dynamic-Based Therapy of Atherosclerosis |
title_full_unstemmed | Recent Advances for Dynamic-Based Therapy of Atherosclerosis |
title_short | Recent Advances for Dynamic-Based Therapy of Atherosclerosis |
title_sort | recent advances for dynamic-based therapy of atherosclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352141/ https://www.ncbi.nlm.nih.gov/pubmed/37469455 http://dx.doi.org/10.2147/IJN.S402678 |
work_keys_str_mv | AT wuguanghao recentadvancesfordynamicbasedtherapyofatherosclerosis AT yuguanye recentadvancesfordynamicbasedtherapyofatherosclerosis AT zhengmeiling recentadvancesfordynamicbasedtherapyofatherosclerosis AT pengwenhui recentadvancesfordynamicbasedtherapyofatherosclerosis AT lilei recentadvancesfordynamicbasedtherapyofatherosclerosis |